Maintenance and pharmacologic targeting of ROR1 protein levels via UHRF1 in t(1;19) pre-B-ALL

Oncogene
Marilynn ChowJeffrey W Tyner

Abstract

Expression of the transmembrane pseudokinase ROR1 is required for survival of t(1;19)-pre-B-cell acute lymphoblastic leukemia (t(1;19) pre-B-ALL), chronic lymphocytic leukemia, and many solid tumors. However, targeting ROR1 with small-molecules has been challenging due to the absence of ROR1 kinase activity. To identify genes that regulate ROR1 expression and may, therefore, serve as surrogate drug targets, we employed an siRNA screening approach and determined that the epigenetic regulator and E3 ubiquitin ligase, UHRF1, is required for t(1;19) pre-B-ALL cell viability in a ROR1-dependent manner. Upon UHRF1 silencing, ROR1 protein is reduced without altering ROR1 mRNA, and ectopically expressed UHRF1 is sufficient to increase ROR1 levels. Additionally, proteasome inhibition rescues loss of ROR1 protein after UHRF1 silencing, suggesting a role for the proteasome in the UHRF1-ROR1 axis. Finally, we show that ROR1-positive cells are twice as sensitive to the UHRF1-targeting drug, naphthazarin, and undergo increased apoptosis compared to ROR1-negative cells. Naphthazarin elicits reduced expression of UHRF1 and ROR1, and combination of naphthazarin with inhibitors of pre-B cell receptor signaling results in further reduction of cel...Continue Reading

References

Sep 29, 1999·Proceedings of the National Academy of Sciences of the United States of America·J R McWhirterC Murre
Feb 13, 2003·British Journal of Haematology·Robin FoaFranco Mandelli
Jun 9, 2005·The Journal of Experimental Medicine·Niklas FeldhahnMarkus Müschen
Oct 31, 2007·Molecular and Cellular Biology·Panagiota KaragianniJiemin Wong
Jan 29, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sivasubramanian BaskarChristoph Rader
Feb 22, 2008·Proceedings of the National Academy of Sciences of the United States of America·Tetsuya FukudaThomas J Kipps
Jun 12, 2008·International Journal of Cancer. Journal International Du Cancer·Amir H DaneshmaneshHodjattallah Rabbani
Dec 6, 2008·Nucleic Acids Research·Jong Kyong KimSriharsa Pradhan
May 13, 2009·Proceedings of the National Academy of Sciences of the United States of America·Jeffrey W TynerBrian J Druker
Nov 10, 2009·Blood·Anthony V MoormanStephen J Proctor
Dec 23, 2009·Nucleic Acids Research·Andrea RottachHeinrich Leonhardt
Dec 15, 2010·Molecular and Cellular Biology·Andrew J KuehTim Thomas
Feb 26, 2011·Cancer·Alexandros DaskalosTriantafillos Liloglou
Apr 13, 2011·Acta Physiologica·M KauckáV Bryja
Apr 14, 2011·Cancer Research·Alessandra GentilePaolo M Comoglio
Jun 15, 2011·Apoptosis : an International Journal on Programmed Cell Death·Bipul R AcharyaGopal Chakrabarti
Apr 26, 2012·MAbs·Sivasubramanian BaskarChristoph Rader
May 17, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Mignon L Loh, Charles G Mullighan
Oct 9, 2012·The American Journal of Pathology·Suping ZhangThomas J Kipps
Mar 9, 2013·Cancer Discovery·Takaomi SandaA Thomas Look
May 25, 2013·Blood·Birte NiebuhrCarol Stocking
Jan 1, 2014·Proceedings of the National Academy of Sciences of the United States of America·George F WidhopfThomas J Kipps
Feb 4, 2014·Cancer Cell·Raksha MudbharyKirsten C Sadler
Apr 23, 2014·Protein & Cell·Nicholas BorcherdingWeizhou Zhang
May 23, 2015·Epigenetics : Official Journal of the DNA Methylation Society·Xiaoyu QuMin Fang

❮ Previous
Next ❯

Citations

Sep 15, 2021·Technology in Cancer Research & Treatment·Cheng-You JiaDa Fu

❮ Previous
Next ❯

Methods Mentioned

BETA
glycosylation
co-immunoprecipitation
Assay
ubiquitination
GTPase
transfection
flow cytometry

Software Mentioned

Prism
FlowJo
GraphPad
ImageJ

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.